Chronic leukemia patients calling for expanded insurance benefit

Published: 2003-01-21 06:58:00

Updated: 2003-01-21 06:58:00

The group of leukemia patients, Glivec publicity group and civil organizations staged a rally in front of the Korea Food and Drug Administration (KFDA) on January 16, urging that more insurance benefits be provided to chronic myelongenous leukemia (CML) patients.

According to Glivec publicity...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK